Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics

被引:573
作者
Macfarlane, G. T. [1 ]
Steed, H. [1 ]
Macfarlane, S. [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Gut Grp, Dundee DD1 9SY, Scotland
关键词
bifidobacteria; fermentation; fructo-oligosaccharides; galacto-oligosaccharides; gut bacteria; gut health; immunomodulation; prebiotics;
D O I
10.1111/j.1365-2672.2007.03520.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Most studies involving prebiotic oligosaccharides have been carried out using inulin and its fructo-oligosaccharide (FOS) derivatives, together with various forms of galacto-oligosaccharides (GOS). Although many intestinal bacteria are able to grow on these carbohydrates, most investigations have demonstrated that the growth of bifidobacteria, and to a lesser degree lactobacilli, is particularly favoured. Because of their safety, stability, organoleptic properties, resistance to digestion in the upper bowel and fermentability in the colon, as well as their abilities to promote the growth of beneficial bacteria in the gut, these prebiotics are being increasingly incorporated into the Western diet. Inulin-derived oligosaccharides and GOS are mildly laxative, but can result in flatulence and osmotic diarrhoea if taken in large amounts. However, their effects on large bowel habit are relatively minor. Although the literature dealing with the health significance of prebiotics is not as extensive as that concerning probiotics, considerable evidence has accrued showing that consumption of GOS and FOS can have significant health benefits, particularly in relation to their putative anti-cancer properties, influence on mineral absorption, lipid metabolism, and anti-inflammatory and other immune effects such as atopic disease. In many instances, prebiotics seem to be more effective when used as part of a synbiotic combination.
引用
收藏
页码:305 / 344
页数:40
相关论文
共 263 条
[1]  
Abe C, 2004, INT J TISSUE REACT, V26, P65
[2]  
Abrams SA, 2005, AM J CLIN NUTR, V82, P471
[3]   Production of galacto-oligosaccharides from lactose by Aspergillus oryzae β-galactosidase immobilized on cotton cloth [J].
Albayrak, N ;
Yang, ST .
BIOTECHNOLOGY AND BIOENGINEERING, 2002, 77 (01) :8-19
[4]   Markers to measure immunomodulation in human nutrition intervention studies [J].
Albers, R ;
Antoine, JM ;
Bourdet-Sicard, R ;
Calder, PC ;
Gleeson, M ;
Lesourd, B ;
Samartín, S ;
Sanderson, IR ;
Van Loo, J ;
Vas Dias, FW ;
Watzl, B .
BRITISH JOURNAL OF NUTRITION, 2005, 94 (03) :452-481
[5]  
Alles MS, 1999, AM J CLIN NUTR, V69, P980
[6]  
Alles MS, 1999, AM J CLIN NUTR, V69, P64
[7]   Fate of fructo-oligosaccharides in the human intestine [J].
Alles, MS ;
Hautvast, JGA ;
Nagengast, FM ;
Hartemink, R ;
vanLaere, KMJ ;
Jansen, JBMJ .
BRITISH JOURNAL OF NUTRITION, 1996, 76 (02) :211-221
[8]  
Angus F., 2005, PROBIOTIC DAIRY PROD, P120
[9]   90-day oral (gavage) study in rats with galactooligosaccharides syrup [J].
Anthony, Joshua C. ;
Merriman, Todd N. ;
Heimbach, James T. .
FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (06) :819-826
[10]   Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides [J].
Asahara, T ;
Nomoto, K ;
Shimizu, K ;
Watanuki, M ;
Tanaka, R .
JOURNAL OF APPLIED MICROBIOLOGY, 2001, 91 (06) :985-996